Upper aerodigestive tract lymphoma in Taiwan

Journal of Clinical Pathology

Volumn 63, Issue 10, 2010, Pages 888-893

  Chen, Shang Wen ^a   Chang, Sheng Tsung ^b   Lu, Chin Li ^a   Hwang, Wei Shou ^a   Tsao, Chao Jung ^a   Huang, Wen Tsung ^a   Chang, Kwang Yu ^c,d   Chuang, Shih Sung ^b,e  

^a Chi Mei Medical Centre   (Taiwan)

^b Chi Mei Medical Centre   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

ADULT; AGED; ARBOVIRUS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CHILD; CONTROLLED STUDY; DEATH; EPSTEIN BARR VIRUS; FEMALE; FOLLICULAR LYMPHOMA; HAZARD RATIO; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MOUTH CAVITY; MULTIVARIATE ANALYSIS; NK T CELL LYMPHOMA; OVERALL SURVIVAL; PERIPHERAL T CELL LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY SYSTEM; RETROSPECTIVE STUDY; SCHOOL CHILD; STATISTICAL ANALYSIS; T LYMPHOCYTE; TAIWAN; UNIVARIATE ANALYSIS; UPPER GASTROINTESTINAL TRACT; WALDEYER RING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; EPIDEMIOLOGIC METHODS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; L-LACTATE DEHYDROGENASE; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77957839452     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.081927     Document Type: Article

References (37)

1. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252-60.
2. Otter R, Bieger R, Kluin PM, et al. Primary gastrointestinal non-Hodgkin's lymphoma in a population-based registry. Br J Cancer 1989;60:745-50.
3. Isaacson P, Norton AJ. Extranodal lymphoma. London: Churchill Livingstone, 1994.
4. Chuang SS, Lin CN, Li CY. Malignant lymphoma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms. Cancer 2000;89:1586-92.
5. Gurkaynak M, Cengiz M, Akyurek S, et al. Waldeyer's ring lymphomas: treatment results and prognostic factors. Am J Clin Oncol 2003;26:437-40. (Pubitemid 37248258)
6. Laskar S, Mohindra P, Gupta S, et al. Non-Hodgkin lymphoma of the Waldeyer's ring: clinicopathologic and therapeutic issues. Leuk Lymphoma 2008;49:2263-71.
7. Lu D, Lin CN, Chuang SS, et al. T-cell and NK/T-cell lymphomas in southern Taiwan: a study of 72 cases in a single institute. Leuk Lymphoma 2004;45:923-8. (Pubitemid 38444668)
8. Li CC, Tien HF, Tang JL, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 2004;100:366-75.
9. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia 2005;19:2186-94.
10. Al-Hakeem DA, Fedele S, Carlos R, et al. Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol 2007;43:4-14. (Pubitemid 46162254)
11. Chuang SS, Chang ST, Chuang WY, et al. NK-cell lineage predicts poor survival in primary intestinal NK-cell and T-cell lymphomas. Am J Surg Pathol 2009;33:1230-40.
12. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC, 2008.
13. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-82.
14. Muris JJ, Meijer CJ, Vos W, et al. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. J Pathol 2006;208:714-23.
15. Chuang SS, Chang ST, Lee YH, et al. Prostatic involvement by nasal NK/T cell lymphoma forming lymphoepithelial lesions. J Clin Pathol 2008;61:399-400.
16. Nakamura S, Jaffe ES, Swerdlow SH. EBV positive diffuse large B-cell lymphoma of the elderly. In: Swerdlow SH CE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, eds. WHO classification of tumours of haemtopoietic and lymphoid tissues. Lyon: IARC, 2008:243-4.
17. Ott G, Kalla J, Ott MM, et al. The Epstein-Barr virus in malignant non-Hodgkin's lymphoma of the upper aerodigestive tract. Diagn Mol Pathol 1997;6:134-9. (Pubitemid 27423837)
18. Krol AD, Le Cessie S, Snijder S, et al. Waldeyer's ring lymphomas: a clinical study from the Comprehensive Cancer Center West population based NHL registry. Leuk Lymphoma 2001;42:1005-13. (Pubitemid 32827522)
19. Ezzat AA, Ibrahim EM, El Weshi AN, et al. Localized non-Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patients. Head Neck 2001;23:547-58.
20. Lopez-Guillermo A, Colomo L, Jimenez M, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005;23:2797-804. (Pubitemid 46179470)
21. Chang DT, Mendenhall NP, Lynch JW, et al. Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ring. Am J Clin Oncol 2009;32:233-7.
22. Sato Y, Onishi N, Morito T, et al. Patients with localized primary non-tonsillar oral diffuse large B-cell lymphoma exhibit favorable prognosis despite a non-germinal center B-cell-like phenotype. Cancer Sci 2009;100:42-6.
23. Kanungo A, Medeiros LJ, Abruzzo LV, et al. Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis. Mod Pathol 2006;19:25-33. (Pubitemid 43250976)
24. Savage KJ, Johnson NA, Ben-Neriah S, et al. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood 2009;114:3533-7.
25. Chuang SS, Ye H, Yang SF, et al. Perforation predicts poor prognosis in patients with primary intestinal diffuse large B-cell lymphoma. Histopathology 2008;53:432-40.
26. Ruzinova MB, Caron T, Rodig SJ. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation. Am J Surg Pathol 2010;34:882-91.
27. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-47. (Pubitemid 34651353)
28. Cuadra-Garcia I, Proulx GM, Wu CL, et al. Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital. Am J Surg Pathol 1999;23:1356-69. (Pubitemid 29517329)
29. Oprea C, Cainap C, Azoulay R, et al. Primary diffuse large B-cell non-Hodgkin lymphoma of the paranasal sinuses: a report of 14 cases. Br J Haematol 2005;131:468-71. (Pubitemid 43899643)
30. Chim CS, Ma SY, Au WY, et al. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 2004;103:216-21.
31. Huang WT, Chang KC, Huang GC, et al. Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer/T-cell lymphoma, nasal type. Haematologica 2005;90:1063-9.
32. Yamaguchi M, Suzuki R, Kwong YL, et al. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 2008;99:1016-20. (Pubitemid 351997606)
33. Kim SJ, Kim K, Kim BS, et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study. J Clin Oncol 2009;27:6027-32.
34. Yamaguchi M, Tobinai K, Oguchi M, et al. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol 2009;27:5594-600.
35. Oyama T, Ichimura K, Suzuki R, et al. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 2003;27:16-26. (Pubitemid 36014895)
36. Oyama T, Yamamoto K, Asano N, et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 2007;13:5124-32. (Pubitemid 47502080)
37. Hoeller S, Tzankov A, Pileri SA, et al. Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations. Hum Pathol 2010;41:352-7.